Recent Quotes (30 days)

You have no recent quotes
chg | %

PharmAust Limited  

(Public, ASX:PAA)   Watch this stock  
Find more results for ASX: PAA
+0.0040 (7.41%)
Feb 23 - Close
ASX data delayed by 20 mins - Disclaimer
Currency in AUD
Range 0.05 - 0.06
52 week 0.05 - 0.09
Open 0.05
Vol / Avg. 419,632.00/466,964.00
Mkt cap 11.39M
P/E     -
Div/yield     -
EPS -0.01
Shares 157.34M
Beta     -
Inst. own     -

Key stats and ratios

Q2 (Jun '17) 2017
Net profit margin -54.92% -40.31%
Operating margin -53.49% -38.52%
EBITD margin - -34.83%
Return on average assets -22.11% -18.59%
Return on average equity -26.04% -22.51%
Employees 52 -
CDP Score - -


U 39 1 Freshwater Pde
+61-8-63640899 (Phone)
+61-8-94676111 (Fax)

Website links


Pharmaust Limited is a drug discovery and development company. The principal activities of the Company are to develop its own drug discovery intellectual property, namely approximately three platforms for the treatment of different types of cancers in humans and animals, as well as providing specialized medicinal and synthetic chemistry services on a contract basis to clients. The Company's segments are Corporate and Pharmaceutical. The Pharmaceutical segment provides products and services in synthetic and medicinal chemistry to the drug discovery and pharmaceutical industries. The Corporate segment covers all the corporate overhead expenses. Its subsidiaries include Pitney Pharmaceuticals Pty Ltd, which is engaged in business of developing therapeutic cancer products, and Epichem Pty Ltd, which offers a range of rare and hard to find pharmaceutical impurities, degradants and metabolites of active ingredients and excipients, particularly for over-the-counter and generic drugs.

Officers and directors

Roger Aston Ph.D. Executive Chairman of the Board
Richard Miles Hopkins Chief Executive Officer
Robert Charles Bishop Executive Director
Wayne Morris Best Managing Director of Epichem Pty Ltd., Director
John Horton Director of Epichem Pty Ltd
Colette G. Sims Director of Epichem Pty Ltd
Sam Michael Wright Company Secretary, Non-Executive Independent Director